![Monica Gangal](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Monica Gangal
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Monica Gangal via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Operating Officer | |
RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
UBS Securities LLC
![]() UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Managers | Analyst-Equity | |
JPMorgan Securities LLC
![]() JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Managers | Analyst-Equity | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
RENOVARO INC. | Biotechnology | Director/Board Member | |
PROBILITY MEDIA CORPORATION | Miscellaneous Commercial Services | Director/Board Member | |
HEPION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Stifel, Nicolaus & Co., Inc.
![]() Stifel, Nicolaus & Co., Inc. Investment ManagersFinance Stifel, Nicolaus & Co., Inc. (Stifel) is a dual-registered broker-dealer and investment adviser headquartered in St. Louis, Missouri. Founded in 1890, the firm is a subsidiary of Stifel Financial Corp. (NYSE: SF), a financial service holding company. Stifel provides full-service brokerage and investment advisory services to individuals and their families, institutions and businesses, and financial advisors. | Investment Managers | Analyst-Equity | |
Appligene Oncor SA
![]() Appligene Oncor SA Pharmaceuticals: OtherHealth Technology Part of Valiant Co., Ltd., Appligene Oncor SA is a French company that specializes in medicinal chemicals and botanical products. The company is based in Illkirch Graffenstaden, France. The company was founded by Daniel Dupret. Appligene Oncor was acquired by Quantum Biotechnologies, Inc. on February 17, 1999 for $1.24 million. | Pharmaceuticals: Other | Chief Executive Officer | |
Institut National des Sciences Appliquées de Lyon | College/University | Undergraduate Degree | |
BioNJ, Inc.
![]() BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Chairman | |
NANOVIRICIDES, INC. | Pharmaceuticals: Major | Director/Board Member | |
MARIZYME, INC. | Biotechnology | Chief Executive Officer | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
ZYVERSA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ONCONETIX, INC. | Pharmaceuticals: Major | Chairman | |
TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer | |
METASTAT, INC. | Electrical Products | Comptroller/Controller/Auditor | |
Tulane University (Louisiana) | College/University | Undergraduate Degree | |
BIOPHYTIS S.A. | Pharmaceuticals: Other | Director of Finance/CFO | |
Biophytis, Inc.
![]() Biophytis, Inc. Pharmaceuticals: MajorHealth Technology Part of Biophytis SA, Biophytis, Inc. operates as a clinical-stage biotechnology company which develops therapeutics for aging and improving functional outcomes. The company is based in Newark, DE. | Pharmaceuticals: Major | Director of Finance/CFO | |
University of Florida | College/University | Masters Business Admin | |
Protéus SA
![]() Protéus SA BiotechnologyHealth Technology Protéus SA discovers, engineers, and manufactures proteins for industrial applications. It operates as a biotechnology company that focuses on the discovery, engineering and manufacturing of proteins of industrial interest, and on the development of protein-based bioprocesses. The company was founded on August 11, 1998 and is headquartered in Paris, France. | Biotechnology | Chief Executive Officer | |
University of Strasbourg | College/University | Doctorate Degree | |
St. John's University | College/University | Undergraduate Degree | |
TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
RELMADA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Rutgers Business School | College/University | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 33 |
France | 6 |
Canada | 3 |
Sectorielle
Health Technology | 21 |
Consumer Services | 8 |
Finance | 7 |
Commercial Services | 6 |
Producer Manufacturing | 2 |
Opérationnelle
Director/Board Member | 22 |
Corporate Officer/Principal | 13 |
Independent Dir/Board Member | 12 |
Chief Executive Officer | 8 |
President | 6 |
Relations les plus connectées
Insiders | |
---|---|
James Sapirstein | 26 |
Maged Shenouda | 16 |
Daniel Schneiderman | 8 |
Daniel Dupret | 7 |
Ted Stover | 4 |
- Bourse
- Insiders
- Monica Gangal
- Connexions Sociétés